tiprankstipranks
Advertisement
Advertisement
PremiumCompany AnnouncementsOncoinvent Sets April Webcast as Radspherin Program Gains Momentum
2M ago
Premium
Company Announcements
Oncoinvent Publishes 2025 Annual Report as Radspherin Program Advances
2M ago
Oncoinvent Secures Key Chinese Patent for Lead Radiopharmaceutical Radspherin
Premium
Company Announcements
Oncoinvent Secures Key Chinese Patent for Lead Radiopharmaceutical Radspherin
3M ago
Oncoinvent Grants New CEO Multiyear Share Option Package Tied to Long-Term Growth
PremiumCompany AnnouncementsOncoinvent Grants New CEO Multiyear Share Option Package Tied to Long-Term Growth
5M ago
Oncoinvent Reshapes Capital Structure After Extraordinary General Meeting
Premium
Company Announcements
Oncoinvent Reshapes Capital Structure After Extraordinary General Meeting
5M ago
Oncoinvent Revamps Option Scheme and Issues New Grants After BerGenBio Merger
Premium
Company Announcements
Oncoinvent Revamps Option Scheme and Issues New Grants After BerGenBio Merger
6M ago
Oncoinvent ASA Completes Major Rights Issue
PremiumCompany AnnouncementsOncoinvent ASA Completes Major Rights Issue
7M ago
Oncoinvent ASA Completes NOK 130 Million Rights Issue to Bolster Cancer Therapy Development
Premium
Company Announcements
Oncoinvent ASA Completes NOK 130 Million Rights Issue to Bolster Cancer Therapy Development
7M ago
Oncoinvent ASA Completes Subscription Period for Rights Issue
Premium
Company Announcements
Oncoinvent ASA Completes Subscription Period for Rights Issue
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100